Source link : https://newshealth.biz/health-news/first-line-osimertinib-plus-chemo-extends-survival-in-nsclc/
The FLAURA2 trial establishes a new standard of care for EGFR-mutated NSCLC, according to the authors of new research. Medscape Medical News Source link : https://www.medscape.com/viewarticle/first-line-osimertinib-plus-chemo-extends-survival-nsclc-2025a1000nll?src=rss Author : Publish date : 2025-09-08 00:28:00 Copyright for syndicated content belongs to the linked Source.
The post First-Line Osimertinib Plus Chemo Extends Survival in NSCLC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-08 00:28:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8